Surgery News and Research

RSS

New prostate cancer screening advances improve early detection

Did you know that about 1 in 8 men will be diagnosed with prostate cancer during their lifetime? According to the American Cancer Society, it remains the second-leading cause of cancer death among American men.

6 Sep 2026

Childhood obesity prescriptions for GLP-1 drugs surge in the U.S.

Although the number of US children under age 12 with obesity being prescribed the weight loss drugs Saxenda, Wegovy, and Zepbound remains low, the number is 310 times higher in June 2026 than it was in 2019, when the drugs were initially prescribed, a new study shows.

4 Sep 2026

The obesity-microbiome story is more complicated than ‘good’ and ‘bad’ bacteria

This review finds that obesity is linked to reciprocal interactions between diet, the gut microbiome, microbial metabolites, and host metabolic pathways that influence appetite, insulin sensitivity, inflammation, and energy balance across the lifespan. It highlights diet as a particularly tractable way to influence this system, while emphasizing that microbiome changes associated with GLP-1 therapies remain difficult to separate from weight loss and that functional multi-omics approaches may help enable more personalized interventions.

3 Sep 2026

Cancer-fighting T cells need small amounts of ROS to attack tumors, study finds

New research reveals a promising new target for treating cancer by harnessing a type of molecule previously thought to do more harm than good.

3 Sep 2026

Study identifies education as a key predictor of hip surgery recovery

Level of education is the socio-economic factor most strongly associated with survival rates after acute hip surgery. This is shown in a Linköping University study of 58,000 people.

3 Sep 2026

Biodegradable 'nanobone' material helps body regrow jawbone

For children born with cleft lip and palate, repairing gaps in the jawbone often means waiting until they are 10 to 12 years old before undergoing invasive bone graft surgery.

3 Sep 2026

IBD patients with family cancer history more likely to develop colorectal cancer

People with inflammatory bowel disease (IBD) who have several close relatives with colorectal cancer are significantly more likely to develop the disease themselves.

3 Sep 2026

Study reveals why many patients fail to recover after stroke

A clot forms. Blood flow to the brain is blocked. Starved of oxygen, neurons begin to die.

2 Sep 2026

Post-surgery immunotherapy may not benefit specific lung cancer patients

A new real-world observational study has found that adding adjuvant immunotherapy after surgery does not significantly improve survival outcomes in patients with resectable non-small cell lung cancer (NSCLC) who have already achieved a pathological complete response (pCR) following neoadjuvant chemoimmunotherapy.

2 Sep 2026

Plant-based fats improve long-term survival for prostate cancer patients

Men diagnosed with nonmetastatic prostate cancer can generally expect to live for many years after their diagnosis. However, cardiovascular disease and other cancers remain important threats to their long-term health.

2 Sep 2026

Giving immunotherapy before surgery boosts brain tumor treatment success

A team from UNIGE and HUG has shown that administering cell immunotherapy before surgery to remove a brain tumor is significantly more effective than administering it afterwards.

2 Sep 2026

Muscle matters: Simple scan could predict heart surgery risks

Around one in four heart surgery patients develop serious lung complications – but a new Adelaide-led study is testing a simple bedside scan that could predict who is most at risk before symptoms appear.

2 Sep 2026

ECG-CLIP improves heart disease detection using less labeled data

Clinicians often use a medical test called a 12-lead electrocardiogram (ECG) to diagnose heart problems, which uses electrodes placed on the chest and limbs to record the heart's electrical activity.

1 Sep 2026

Certain diabetes patients face higher ketoacidosis risk with SGLT2 drugs

Patients with type 2 diabetes who have high blood glucose levels, low body weight, or a history of ketoacidosis are at increased risk of developing this serious condition when treated with so-called SGLT2 inhibitors.

1 Sep 2026

Penn Medicine tests FLASH proton therapy for cancer patients

A new form of proton therapy-designed to deliver cancer-killing radiation therapy in less than a second, through fewer total sessions, with potentially less risk of damaging side effects-is now being tested in a Phase I clinical trial at the Abramson Cancer Center of the University of Pennsylvania.

1 Sep 2026

Study reveals how melanoma weakens skin cell immune defenses

Cancers actively remodel their surrounding cells and tissues to create a microenvironment that favors their growth, survival, and spread.

1 Sep 2026

Immunotherapy shows potential for treating rising gynecological tumors

Gynecological tumors, including cervical cancer (CC), endometrial cancer (EC), and ovarian cancer (OC), represent a significant global health burden for women.

1 Sep 2026

Laser-based therapy shows promise against dangerous abdominal infections in children

Children whose appendix has burst often develop serious abdominal infections that are hard to treat and increasingly resistant to antibiotics.

1 Sep 2026

Early-onset bowel cancer shows distinct biological and clinical features

One of Australia's largest real world studies of younger adults with advanced bowel cancer has identified important differences between cancers diagnosed before and after the age of 50, which could help doctors tailor treatments for younger adults more effectively.

1 Sep 2026

Semaglutide did more than cut weight in this analysis of 6,239 adults

A systematic review and meta-analysis of nine randomized controlled trials involving 6,239 adults with overweight or obesity without diabetes found that subcutaneous semaglutide produced substantially greater reductions in body weight, waist circumference, and C-reactive protein than placebo. The higher dose of 7.2 mg semaglutide showed potential for greater weight loss, although the evidence is largely based on a single trial and requires confirmation.

31 Aug 2026